- Home
- DHC vs HUMA Comparison
DHC vs HUMA Comparison
Compare DHC & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHC
- HUMA
- Stock Information
- Founded
- DHC 1998
- HUMA 2004
- Country
- DHC United States
- HUMA United States
- Employees
- DHC N/A
- HUMA N/A
- Industry
- DHC Real Estate Investment Trusts
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- DHC Real Estate
- HUMA Health Care
- Exchange
- DHC Nasdaq
- HUMA Nasdaq
- Market Cap
- DHC 629.7M
- HUMA 577.7M
- IPO Year
- DHC N/A
- HUMA N/A
- Fundamental
- Price
- DHC $2.44
- HUMA $3.80
- Analyst Decision
- DHC Hold
- HUMA Strong Buy
- Analyst Count
- DHC 3
- HUMA 7
- Target Price
- DHC $4.50
- HUMA $12.71
- AVG Volume (30 Days)
- DHC 856.3K
- HUMA 2.6M
- Earning Date
- DHC 11-04-2024
- HUMA 11-08-2024
- Dividend Yield
- DHC 1.66%
- HUMA N/A
- EPS Growth
- DHC N/A
- HUMA N/A
- EPS
- DHC N/A
- HUMA N/A
- Revenue
- DHC $1,477,343,000.00
- HUMA N/A
- Revenue This Year
- DHC N/A
- HUMA N/A
- Revenue Next Year
- DHC $5.26
- HUMA $6,438.24
- P/E Ratio
- DHC N/A
- HUMA N/A
- Revenue Growth
- DHC 6.62
- HUMA N/A
- 52 Week Low
- DHC $2.19
- HUMA $2.48
- 52 Week High
- DHC $4.24
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- DHC 34.07
- HUMA 36.01
- Support Level
- DHC $2.33
- HUMA $4.01
- Resistance Level
- DHC $2.50
- HUMA $4.38
- Average True Range (ATR)
- DHC 0.11
- HUMA 0.34
- MACD
- DHC 0.02
- HUMA -0.01
- Stochastic Oscillator
- DHC 26.83
- HUMA 16.27
About DHC Diversified Healthcare Trust of Beneficial Interest
Diversified Healthcare Trust is a real estate investment trust that focuses on healthcare-related properties, including life science estates, medical offices, and senior living communities. It acquires and owns properties and is engaged in the development and implementation of medical services and technologies. It operates through two segments: Office Portfolio and SHOP. The office portfolio includes medical office properties leased to medical-related businesses and life sciences properties. The SHOP segment runs communities that offer multiple types of residential care, ranging from independent living to nursing services. DHT operates across the United States and the majority of its revenue derives from rents and medical programs.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.